David Alagille

2.2k total citations
87 papers, 1.7k citations indexed

About

David Alagille is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, David Alagille has authored 87 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 25 papers in Cellular and Molecular Neuroscience and 16 papers in Physiology. Recurrent topics in David Alagille's work include Receptor Mechanisms and Signaling (18 papers), Neuroscience and Neuropharmacology Research (16 papers) and Medical Imaging Techniques and Applications (10 papers). David Alagille is often cited by papers focused on Receptor Mechanisms and Signaling (18 papers), Neuroscience and Neuropharmacology Research (16 papers) and Medical Imaging Techniques and Applications (10 papers). David Alagille collaborates with scholars based in United States, France and Japan. David Alagille's co-authors include Gilles Tamagnan, Ronald M. Baldwin, Olivier Barret, John Seibyl, Kenneth Marek, P. Jeffrey Conn, Caroline Papin, Danna Jennings, Thomas Morley and Adriana Tavares and has published in prestigious journals such as Brain, Neurology and Journal of Medicinal Chemistry.

In The Last Decade

David Alagille

85 papers receiving 1.7k citations

Peers

Countries citing papers authored by David Alagille

Since Specialization

Citations

This map shows the geographic impact of David Alagille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Alagille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Alagille more than expected).

Fields of papers citing papers by David Alagille

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Alagille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Alagille. The network helps show where David Alagille may publish in the future.

Co-authorship network of co-authors of David Alagille

This figure shows the co-authorship network connecting the top 25 collaborators of David Alagille. A scholar is included among the top collaborators of David Alagille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Alagille. David Alagille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical characterization of [18F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Tatsuki Koike, Cristian Constantinescu, Shuhei Ikeda, Toshiya Nishi, (unknown), Maki Miyamoto, Patricia E. Cole, Olivier Barret, David Alagille, Caroline Papin, Thomas Morley, Krista Fowles, John Seibyl, Gilles Tamagnan, Takanobu Kuroita	12
2	[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Sandra Sanabria Bohórquez, Jan Mařı́k, Annie Ogasawara, Jeff N. Tinianow, Herman Gill, Olivier Barret, Gilles Tamagnan, David Alagille, Gai Ayalon, Paul T. Manser, Thomas Bengtsson, Michael E. Ward, Simon‐Peter Williams, Geoffrey A. Kerchner, John Seibyl, Kenneth Marek, Robby M. Weimer	82
3	Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers 2018 ·Molecular Imaging and Biology ·Cristian Constantinescu, Cédric Tresse, Ming‐Qiang Zheng, (unknown), Vincent M. Carroll, (unknown), David Alagille, Christine Sandiego, Caroline Papin, Kenneth Marek, John Seibyl, Gilles Tamagnan, Olivier Barret	52
4	Brain distribution of MS565, an imaging analogue of siponimod (BAF312), in non-human primates 2014 ·European Journal of Neurology ·Adriana Tavares, Olivier Barret, David Alagille, Thomas Morley, Caroline Papin, R. P. Maguire, Emmanuelle Briard, Yves P. Auberson, Gilles Tamagnan	6
5	Brain Distribution of MS565, an Imaging Analogue of Siponimod (BAF312), in Non-human Primates (P1.168) 2014 ·Neurology ·Adriana Tavares, Olivier Barret, David Alagille, Thomas Morley, Caroline Papin, R. P. Maguire, Emmanuelle Briard, Yves P. Auberson, Gilles Tamagnan	9
6	Adenosine 2A Receptor Occupancy by Tozadenant and Preladenant in Rhesus Monkeys 2014 ·Journal of Nuclear Medicine ·Olivier Barret, Jonas Hannestad, David Alagille, (unknown), Adriana Tavares, Caroline Papin, Thomas Morley, Krista Fowles, Hsiaoju Lee, John Seibyl, D. Tytgat, Marc Laruelle, Gilles Tamagnan	29
7	In Vivo Assessment and Dosimetry of 2 Novel PDE10A PET Radiotracers in Humans: ¹⁸F-MNI-659 and ¹⁸F-MNI-654 2014 ·Journal of Nuclear Medicine ·Olivier Barret, David Thomae, Adriana Tavares, David Alagille, Caroline Papin, Rikki N. Waterhouse, Timothy J. McCarthy, Danna Jennings, Kenneth Marek, David Russell, John Seibyl, Gilles Tamagnan	51
8	In vivo evaluation of [123I]MNI-420: A novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain 2013 ·Nuclear Medicine and Biology ·Adriana Tavares, Jeffery C. Batis, Olivier Barret, David Alagille, (unknown), (unknown), Andrei O. Koren, Kelly Cosgrove, (unknown), Jeffrey H. Kordower, John Seibyl, Gilles Tamagnan	12
9	Microfluidic continuous-flow radiosynthesis of [¹⁸F]FPEB suitable for human PET imaging 2013 ·MedChemComm ·Steven H. Liang, Daniel Yokell, (unknown), Peter A. Rice, Ronald J. Callahan, Keith A. Johnson, David Alagille, Gilles Tamagnan, Thomas Collier, Neil Vasdev	25
10	First in vivo assessment of two PDE10 tracers [18F]MNI654 and [18F]MNI659 2012 ·Olivier Barret, David Thomae, David Alagille, Hsiaoju Lee, Caroline Papin, Ronald M. Baldwin, Danna Jennings, Kenneth Marek, John Seibyl, Gilles Tamagnan	9
11	In vivo evaluation of [123I]mZIENT as a SPECT radioligand for the serotonin transporter 2012 ·Nuclear Medicine and Biology ·Jeffery C. Batis, Olivier Barret, David Alagille, Andrei O. Koren, Jeffrey S. Stehouwer, Kelly Cosgrove, Mark M. Goodman, John Seibyl, (unknown)	1
12	Potent mGluR5 antagonists: Pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series 2011 ·Bioorganic & Medicinal Chemistry Letters ·David Alagille, (unknown), Yelin Chen, Ruedee Hemstapat, Alice L. Rodriguez, Ronald M. Baldwin, (unknown), Gilles Tamagnan	12
13	A Novel Class of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Interact with a Site Distinct from That of Negative Allosteric Modulators 2006 ·Molecular Pharmacology ·Ruedee Hemstapat, Tomas de Paulis, Yelin Chen, Ashley E. Brady, Vandana K. Grover, David Alagille, Gilles Tamagnan, P. Jeffrey Conn	58
14	Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER 2006 ·Bioorganic & Medicinal Chemistry Letters ·Gilles Tamagnan, (unknown), David Alagille, Julie K. Staley, Colin N. Haile, Andrei O. Koren, Michelle Early, Ronald M. Baldwin, Frank I. Tarazi, Ross J. Baldessarini, Nachwa Jarkas, Mark M. Goodman, John Seibyl	19
15	Synthesis and monoamine transporter affinity of new 2β-carbomethoxy-3β-[aryl or heteroaryl]phenyltropanes 2005 ·Bioorganic & Medicinal Chemistry Letters ·Gilles Tamagnan, David Alagille, Xing Fu, Nora S. Kula, Ross J. Baldessarini, Robert B. Innis, Ronald M. Baldwin	4
16	Synthesis and monoamine transporter affinity of new 2β-carbomethoxy-3β-[4-(substituted thiophenyl)]phenyltropanes: discovery of a selective SERT antagonist with picomolar potency 2004 ·Bioorganic & Medicinal Chemistry Letters ·Gilles Tamagnan, David Alagille, Xing Fu, Nora S. Kula, Ross J. Baldessarini, Robert B. Innis, Ronald M. Baldwin	11
17	[Utilization of epsilon-amino-caproic acid in hemostasis in stomatology in hemophiliacs]. 1965 ·PubMed ·David Alagille, Anne-Sophie Lambert, (unknown), M. Poulain	2
18	[Treatment of Willebrand's disease (angiohemophilia) by coagulant fractions (Fr I-A, Fr I and P.P.B.)]. 1959 ·PubMed ·(unknown), (unknown), David Alagille, (unknown)	2
19	[Thrombopathies associated with congenital cardiopathies; study of hemostasis in 50 cases]. 1958 ·PubMed ·David Alagille, (unknown), J Guéry, (unknown), Pierre Blondeau, C Dubost	3
20	[Practical incidences in analyzing hemophilia]. 1954 ·PubMed ·David Alagille	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact